Reports

Global Varicella Attenuated Live Vaccine Competitive Landscape Professional Research Report 2026

Published：2026-02-10Pages：115Tables and Figures：130

Report ID：BJFL022844Report Format：

Delivery：Within 72h

Full Report Competitor Data

Full Report Selling Price
Single Users License 3500.00 USD
Multi Users License 5250.00 USD
Enterprise Users License 7000.00 USD
Buy Now Contact Us

Competitor Data Selling Price
Single Users License 1000.00 USD
Multi Users License 1500.00 USD
Enterprise Users License 2000.00 USD
Buy Now Contact Us

Important Clause:

Recently, our company has discovered that some websites have plagiarized, cited, and modified our original directories without authorization, seriously infringing on our company’s interests. In order to protect our intellectual property rights, we have decided not to publicly display specific enterprise lists, product segmentation types, and downstream applications. To view the complete content, please request a free sample.

*All report related content displayed on this website is original and our company has the sole copyright in DIReserch. Without prior permission from our company, it is not allowed to modify, reprint or cite in any way. Otherwise, our company reserves the right to pursue legal responsibility.

Research Scope

Table of Contents

Tables and Figures

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Varicella Attenuated Live Vaccine market size will reach 3,116.29 Million USD in 2026 and is projected to reach 4,246.52 Million USD by 2033, with a CAGR of 4.52% (2026-2033). Notably, the China Varicella Attenuated Live Vaccine market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

The Varicella Attenuated Live Vaccine, commonly known as the Varicella vaccine or chickenpox vaccine, is a preventive immunization designed to protect against the varicella-zoster virus, which causes chickenpox. This vaccine is composed of weakened or attenuated live viruses that stimulate the immune system to produce an immune response without causing the disease itself. Administered through a series of doses, the Varicella vaccine is highly effective in preventing chickenpox and reducing the severity of the illness in case of exposure. It is a crucial component of routine childhood immunization schedules in many countries, contributing to the control and prevention of chickenpox outbreaks and associated complications. Additionally, the vaccine has been instrumental in reducing the incidence of herpes zoster (shingles), which can occur later in life as a reactivation of the varicella-zoster virus.

The major global manufacturers of Varicella Attenuated Live Vaccine include Merck, BCHT, Shanghai Institute, GSK, Keygen, Green Cross, Biken, Shanghai Rongsheng Biotech, Sinovac Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Varicella Attenuated Live Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Varicella Attenuated Live Vaccine market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Varicella Attenuated Live Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Varicella Attenuated Live Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Varicella Attenuated Live Vaccine Include:

Merck

BCHT

Shanghai Institute

GSK

Keygen

Green Cross

Biken

Shanghai Rongsheng Biotech

Sinovac Biotech

Varicella Attenuated Live Vaccine Product Segment Include:

Monovalent Vaccine

Combination Vaccine

Varicella Attenuated Live Vaccine Product Application Include:

Kids Injection

Adults Injection

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Varicella Attenuated Live Vaccine Industry PESTEL Analysis

Chapter 3: Global Varicella Attenuated Live Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Varicella Attenuated Live Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Varicella Attenuated Live Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Varicella Attenuated Live Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Varicella Attenuated Live Vaccine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Varicella Attenuated Live Vaccine Product by Type

1.2.1 Monovalent Vaccine

1.2.2 Combination Vaccine

1.3 Varicella Attenuated Live Vaccine Product by Application

1.3.1 Kids Injection

1.3.2 Adults Injection

1.4 Global Varicella Attenuated Live Vaccine Market Revenue and Sales Analysis

1.4.1 Global Varicella Attenuated Live Vaccine Revenue Market Size Analysis (2021-2033)

1.4.2 Global Varicella Attenuated Live Vaccine Sales Market Size Analysis (2021-2033)

1.4.3 Global Varicella Attenuated Live Vaccine Market Sales Price Trend Analysis (2021-2033)

1.5 Varicella Attenuated Live Vaccine Industry Trends and Innovation

1.5.1 Varicella Attenuated Live Vaccine Industry Trends and Innovation

1.5.2 Varicella Attenuated Live Vaccine Market Drivers and Challenges

2 Varicella Attenuated Live Vaccine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Varicella Attenuated Live Vaccine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Varicella Attenuated Live Vaccine Market Analysis by Regions

4.1 Varicella Attenuated Live Vaccine Overall Market: 2025 VS 2026 VS 2033

4.2 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis (2021-2033)

4.2.1 Global Varicella Attenuated Live Vaccine Revenue and Market Share by Region (2021-2026)

4.2.2 Global Varicella Attenuated Live Vaccine Revenue and Market Share Forecast by Region (2027-2033)

4.3 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis (2021-2033)

4.3.1 Global Varicella Attenuated Live Vaccine Sales and Market Share by Region (2021-2026)

4.3.2 Global Varicella Attenuated Live Vaccine Sales and Market Share Forecast by Region (2027-2033)

4.4 Global Varicella Attenuated Live Vaccine Sales Price Trend Analysis (2021-2033)

5 Global Varicella Attenuated Live Vaccine Market Size by Type and Application

5.1 Global Varicella Attenuated Live Vaccine Market Size by Type

5.1.1 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis by Type (2021-2033)

5.1.2 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis by Type (2021-2033)

5.2 Global Varicella Attenuated Live Vaccine Market Size by Application

5.2.1 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis by Application (2021-2033)

5.2.2 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis by Application (2021-2033)

6 North America

6.1 North America Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2021-2033)

6.2 North America Key Manufacturers Analysis

6.3 North America Varicella Attenuated Live Vaccine Market Size by Type

6.3.1 North America Varicella Attenuated Live Vaccine Sales by Type (2021-2033)

6.3.2 North America Varicella Attenuated Live Vaccine Revenue by Type (2021-2033)

6.4 North America Varicella Attenuated Live Vaccine Market Size by Application

6.4.1 North America Varicella Attenuated Live Vaccine Sales by Application (2021-2033)

6.4.2 North America Varicella Attenuated Live Vaccine Revenue by Application (2021-2033)

6.5 North America Varicella Attenuated Live Vaccine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2021-2033)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Varicella Attenuated Live Vaccine Market Size by Type

7.3.1 Europe Varicella Attenuated Live Vaccine Sales by Type (2021-2033)

7.3.2 Europe Varicella Attenuated Live Vaccine Revenue by Type (2021-2033)

7.4 Europe Varicella Attenuated Live Vaccine Market Size by Application

7.4.1 Europe Varicella Attenuated Live Vaccine Sales by Application (2021-2033)

7.4.2 Europe Varicella Attenuated Live Vaccine Revenue by Application (2021-2033)

7.5 Europe Varicella Attenuated Live Vaccine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2021-2033)

8.2 China Key Manufacturers Analysis

8.3 China Varicella Attenuated Live Vaccine Market Size by Type

8.3.1 China Varicella Attenuated Live Vaccine Sales by Type (2021-2033)

8.3.2 China Varicella Attenuated Live Vaccine Revenue by Type (2021-2033)

8.4 China Varicella Attenuated Live Vaccine Market Size by Application

8.4.1 China Varicella Attenuated Live Vaccine Sales by Application (2021-2033)

8.4.2 China Varicella Attenuated Live Vaccine Revenue by Application (2021-2033)

9 APAC (excl. China)

9.1 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2021-2033)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Type

9.3.1 APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Type (2021-2033)

9.3.2 APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Type (2021-2033)

9.4 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Application

9.4.1 APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Application (2021-2033)

9.4.2 APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Application (2021-2033)

9.5 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Southeast Asia

10 Latin America

10.1 Latin America Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2021-2033)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Varicella Attenuated Live Vaccine Market Size by Type

10.3.1 Latin America Varicella Attenuated Live Vaccine Sales by Type (2021-2033)

10.3.2 Latin America Varicella Attenuated Live Vaccine Revenue by Type (2021-2033)

10.4 Latin America Varicella Attenuated Live Vaccine Market Size by Application

10.4.1 Latin America Varicella Attenuated Live Vaccine Sales by Application (2021-2033)

10.4.2 Latin America Varicella Attenuated Live Vaccine Revenue by Application (2021-2033)

10.5 Latin America Varicella Attenuated Live Vaccine Market Size by Country

10.6 Latin America Varicella Attenuated Live Vaccine Market Size by Country

10.6.1 Mexico

10.6.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2021-2033)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Type

11.3.1 Middle East & Africa Varicella Attenuated Live Vaccine Sales by Type (2021-2033)

11.3.2 Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Type (2021-2033)

11.4 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Application

11.4.1 Middle East & Africa Varicella Attenuated Live Vaccine Sales by Application (2021-2033)

11.4.2 Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Application (2021-2033)

11.5 Middle East Varicella Attenuated Live Vaccine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Varicella Attenuated Live Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2026)

12.1.1 Global Varicella Attenuated Live Vaccine Market Sales by Key Manufacturers (2021-2026)

12.1.2 Global Varicella Attenuated Live Vaccine Market Revenue by Key Manufacturers (2021-2026)

12.1.3 Global Varicella Attenuated Live Vaccine Average Sales Price by Manufacturers (2021-2026)

12.2 Varicella Attenuated Live Vaccine Competitive Landscape Analysis and Market Dynamic

12.2.1 Varicella Attenuated Live Vaccine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Merck

13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Merck Varicella Attenuated Live Vaccine Product Portfolio

13.1.3 Merck Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.2 BCHT

13.2.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 BCHT Varicella Attenuated Live Vaccine Product Portfolio

13.2.3 BCHT Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.3 Shanghai Institute

13.3.1 Shanghai Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Shanghai Institute Varicella Attenuated Live Vaccine Product Portfolio

13.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.4 GSK

13.4.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 GSK Varicella Attenuated Live Vaccine Product Portfolio

13.4.3 GSK Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.5 Keygen

13.5.1 Keygen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Keygen Varicella Attenuated Live Vaccine Product Portfolio

13.5.3 Keygen Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.6 Green Cross

13.6.1 Green Cross Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Green Cross Varicella Attenuated Live Vaccine Product Portfolio

13.6.3 Green Cross Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.7 Biken

13.7.1 Biken Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Biken Varicella Attenuated Live Vaccine Product Portfolio

13.7.3 Biken Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.8 Shanghai Rongsheng Biotech

13.8.1 Shanghai Rongsheng Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Portfolio

13.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

13.9 Sinovac Biotech

13.9.1 Sinovac Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Sinovac Biotech Varicella Attenuated Live Vaccine Product Portfolio

13.9.3 Sinovac Biotech Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

14.1 Varicella Attenuated Live Vaccine Industry Chain Analysis

14.2 Varicella Attenuated Live Vaccine Industry Raw Material and Suppliers Analysis

14.2.1 Varicella Attenuated Live Vaccine Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Varicella Attenuated Live Vaccine Typical Downstream Customers

14.4 Varicella Attenuated Live Vaccine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Table 1： Global Varicella Attenuated Live Vaccine Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global Varicella Attenuated Live Vaccine Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： Varicella Attenuated Live Vaccine Industry Development Status

Table 4： Varicella Attenuated Live Vaccine Industry Development Trends

Table 5： Global Varicella Attenuated Live Vaccine Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global Varicella Attenuated Live Vaccine Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2021-2026)

Table 8： Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global Varicella Attenuated Live Vaccine Sales by Region (2021-2026) & (K Doses)

Table 11： Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2021-2026)

Table 12： Global Varicella Attenuated Live Vaccine Sales Forecast by Region (2027-2033) & (K Doses)

Table 13： Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Region (2027-2033)

Table 14： Global Varicella Attenuated Live Vaccine Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 15： Global Varicella Attenuated Live Vaccine Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 16： Global Varicella Attenuated Live Vaccine Sales Analysis by Type (2021-2026) & (K Doses)

Table 17： Global Varicella Attenuated Live Vaccine Sales Analysis Forecast by Type (2027-2033) & (K Doses)

Table 18： Global Varicella Attenuated Live Vaccine Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 19： Global Varicella Attenuated Live Vaccine Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 20： Global Varicella Attenuated Live Vaccine Sales Analysis by Application (2021-2026) & (K Doses)

Table 21： Global Varicella Attenuated Live Vaccine Sales Analysis Forecast by Application (2027-2033) & (K Doses)

Table 22： Key Varicella Attenuated Live Vaccine Players in North America

Table 23： North America Varicella Attenuated Live Vaccine Sales by Type (2021-2026) & (K Doses)

Table 24： North America Varicella Attenuated Live Vaccine Sales by Type (2027-2033) & (K Doses)

Table 25： North America Varicella Attenuated Live Vaccine Revenue by Type (2021-2026) & (US$ Million)

Table 26： North America Varicella Attenuated Live Vaccine Revenue by Type (2027-2033) & (US$ Million)

Table 27： North America Varicella Attenuated Live Vaccine Sales by Application (2021-2026) & (K Doses)

Table 28： North America Varicella Attenuated Live Vaccine Sales by Application (2027-2033) & (K Doses)

Table 29： North America Varicella Attenuated Live Vaccine Revenue by Application (2021-2026) & (US$ Million)

Table 30： North America Varicella Attenuated Live Vaccine Revenue by Application (2027-2033) & (US$ Million)

Table 31： North America Varicella Attenuated Live Vaccine Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 32： North America Varicella Attenuated Live Vaccine Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 33： North America Varicella Attenuated Live Vaccine Sales Market Size by Country (2021-2026) & (K Doses)

Table 34： North America Varicella Attenuated Live Vaccine Sales Market Size by Country (2027-2033) & (K Doses)

Table 35： Key Varicella Attenuated Live Vaccine Players in Europe

Table 36： Europe Varicella Attenuated Live Vaccine Sales by Type (2021-2026) & (K Doses)

Table 37： Europe Varicella Attenuated Live Vaccine Sales by Type (2027-2033) & (K Doses)

Table 38： Europe Varicella Attenuated Live Vaccine Revenue by Type (2021-2026) & (US$ Million)

Table 39： Europe Varicella Attenuated Live Vaccine Revenue by Type (2027-2033) & (US$ Million)

Table 40： Europe Varicella Attenuated Live Vaccine Sales by Application (2021-2026) & (K Doses)

Table 41： Europe Varicella Attenuated Live Vaccine Sales by Application (2027-2033) & (K Doses)

Table 42： Europe Varicella Attenuated Live Vaccine Revenue by Application (2021-2026) & (US$ Million)

Table 43： Europe Varicella Attenuated Live Vaccine Revenue by Application (2027-2033) & (US$ Million)

Table 44： Europe Varicella Attenuated Live Vaccine Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 45： Europe Varicella Attenuated Live Vaccine Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 46： Europe Varicella Attenuated Live Vaccine Sales Market Size by Country (2021-2026) & (K Doses)

Table 47： Europe Varicella Attenuated Live Vaccine Sales Market Size Forecast by Country (2027-2033) & (K Doses)

Table 48： Key Varicella Attenuated Live Vaccine Players in China

Table 49： China Varicella Attenuated Live Vaccine Sales by Type (2021-2026) & (K Doses)

Table 50： China Varicella Attenuated Live Vaccine Sales by Type (2027-2033) & (K Doses)

Table 51： China Varicella Attenuated Live Vaccine Revenue by Type (2021-2026) & (US$ Million)

Table 52： China Varicella Attenuated Live Vaccine Revenue by Type (2027-2033) & (US$ Million)

Table 53： China Varicella Attenuated Live Vaccine Sales by Application (2021-2026) & (K Doses)

Table 54： China Varicella Attenuated Live Vaccine Sales by Application (2027-2033) & (K Doses)

Table 55： China Varicella Attenuated Live Vaccine Revenue by Application (2021-2026) & (US$ Million)

Table 56： China Varicella Attenuated Live Vaccine Revenue by Application (2027-2033) & (US$ Million)

Table 57： Key Varicella Attenuated Live Vaccine Players in APAC (excl. China)

Table 58： APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Type (2021-2026) & (K Doses)

Table 59： APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Type (2027-2033) & (K Doses)

Table 60： APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Type (2021-2026) & (US$ Million)

Table 61： APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Type (2027-2033) & (US$ Million)

Table 62： APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Application (2021-2026) & (K Doses)

Table 63： APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Application (2027-2033) & (K Doses)

Table 64： APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Application (2021-2026) & (US$ Million)

Table 65： APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Application (2027-2033) & (US$ Million)

Table 66:： APAC (excl. China) Varicella Attenuated Live Vaccine Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 67： APAC (excl. China) Varicella Attenuated Live Vaccine Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 68： APAC (excl. China) Varicella Attenuated Live Vaccine Sales Market Size by Country (2021-2026) & (K Doses)

Table 69： APAC (excl. China) Varicella Attenuated Live Vaccine Sales Market Size Forecast by Country (2027-2033) & (K Doses)

Table 70： Key Varicella Attenuated Live Vaccine Players in Latin America

Table 71： Latin America Varicella Attenuated Live Vaccine Sales by Type (2021-2026) & (K Doses)

Table 72： Latin America Varicella Attenuated Live Vaccine Sales by Type (2027-2033) & (K Doses)

Table 73： Latin America Varicella Attenuated Live Vaccine Revenue by Type (2021-2026) & (US$ Million)

Table 74： Latin America Varicella Attenuated Live Vaccine Revenue by Type (2027-2033) & (US$ Million)

Table 75： Latin America Varicella Attenuated Live Vaccine Sales by Application (2021-2026) & (K Doses)

Table 76： Latin America Varicella Attenuated Live Vaccine Sales by Application (2027-2033) & (K Doses)

Table 77： Latin America Varicella Attenuated Live Vaccine Revenue by Application (2021-2026) & (US$ Million)

Table 78： Latin America Varicella Attenuated Live Vaccine Revenue by Application (2027-2033) & (US$ Million)

Table 79： Latin America Varicella Attenuated Live Vaccine Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 80： Latin America Varicella Attenuated Live Vaccine Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 81： Latin America Varicella Attenuated Live Vaccine Sales Market Size by Country (2021-2026) & (K Doses)

Table 82： Latin America Varicella Attenuated Live Vaccine Sales Market Size Forecast by Country (2027-2033) & (K Doses)

Table 83： Key Varicella Attenuated Live Vaccine Players in Middle East & Africa

Table 84： Middle East & Africa Varicella Attenuated Live Vaccine Sales by Type (2021-2026) & (K Doses)

Table 85： Middle East & Africa Varicella Attenuated Live Vaccine Sales by Type (2027-2033) & (K Doses)

Table 86： Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Type (2021-2026) & (US$ Million)

Table 87： Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Type (2027-2033) & (US$ Million)

Table 88： Middle East & Africa Varicella Attenuated Live Vaccine Sales by Application (2021-2026) & (K Doses)

Table 89： Middle East & Africa Varicella Attenuated Live Vaccine Sales by Application (2027-2033) & (K Doses)

Table 90： Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Application (2021-2026) & (US$ Million)

Table 91： Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Application (2027-2033) & (US$ Million)

Table 92： Middle East & Africa Varicella Attenuated Live Vaccine Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 93： Middle East & Africa Varicella Attenuated Live Vaccine Revenue Market Size Forecast by Country (2027-2033) & (US$ Million)

Table 94： Middle East & Africa Varicella Attenuated Live Vaccine Sales Market Size by Country (2021-2026) & (K Doses)

Table 95： Middle East & Africa Varicella Attenuated Live Vaccine Sales Market Size Forecast by Country (2027-2033) & (K Doses)

Table 96： Global Varicella Attenuated Live Vaccine Market Sales by Key Manufacturers (2021-2026) & (K Doses)

Table 97： Global Varicella Attenuated Live Vaccine Sales Market Share by Key Manufacturers (2021-2026)

Table 98： Global Varicella Attenuated Live Vaccine Market Revenue by Key Manufacturers (2021-2026) & (US$ Million)

Table 99： Global Varicella Attenuated Live Vaccine Revenue Market Share by Key Manufacturers (2021-2026)

Table 100： Global Average Sales Price by Manufacturers (2021-2026) & (USD/Dose)

Table 101： Global Key Manufacturers Headquarter Location and Key Area Sales

Table 102： Market Mergers & Acquisitions, Expansion

Table 103： Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 104： Merck Varicella Attenuated Live Vaccine Product Portfolio

Table 105： Merck Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 106： BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 107： BCHT Varicella Attenuated Live Vaccine Product Portfolio

Table 108： BCHT Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 109： Shanghai Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 110： Shanghai Institute Varicella Attenuated Live Vaccine Product Portfolio

Table 111： Shanghai Institute Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 112： GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 113： GSK Varicella Attenuated Live Vaccine Product Portfolio

Table 114： GSK Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 115： Keygen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 116： Keygen Varicella Attenuated Live Vaccine Product Portfolio

Table 117： Keygen Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 118： Green Cross Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 119： Green Cross Varicella Attenuated Live Vaccine Product Portfolio

Table 120： Green Cross Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 121： Biken Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 122： Biken Varicella Attenuated Live Vaccine Product Portfolio

Table 123： Biken Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 124： Shanghai Rongsheng Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 125： Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Portfolio

Table 126： Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 127： Sinovac Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 128： Sinovac Biotech Varicella Attenuated Live Vaccine Product Portfolio

Table 129： Sinovac Biotech Varicella Attenuated Live Vaccine Revenue (US$ Million), Sales (K Doses), Price (USD/Dose), Gross Margin and Market Share (2021-2026)

Table 130： Upstream Key Raw Material Price List

Table 131： Varicella Attenuated Live Vaccine Raw Material Suppliers and Contact Information

Table 132： Varicella Attenuated Live Vaccine Typical Customer List

Table 133： Varicella Attenuated Live Vaccine Distributors List

Figure 1： Varicella Attenuated Live Vaccine Product Pictures

Figure 2： Monovalent Vaccine Picture Scope

Figure 3： Combination Vaccine Picture Scope

Figure 4： Kids Injection Picture Scope

Figure 5： Adults Injection Picture Scope

Figure 6：Global Varicella Attenuated Live Vaccine Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 7：Global Varicella Attenuated Live Vaccine Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 8：Global Varicella Attenuated Live Vaccine Market Sales and Growth Rate Analysis (2021-2033) &（K Doses）

Figure 9：Global Varicella Attenuated Live Vaccine Market Price Trend Analysis (2021-2033) & (USD/Dose)

Figure 10：Global Varicella Attenuated Live Vaccine Market Size by Region (2021-2033) & (US$ Million)

Figure 11：Global Varicella Attenuated Live Vaccine Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 12：Global Varicella Attenuated Live Vaccine Sales Price by Region (2021-2033) & (K Doses)

Figure 13：North America Varicella Attenuated Live Vaccine Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 14：North America Varicella Attenuated Live Vaccine Revenue Market Share by Players in 2025

Figure 15：North America Varicella Attenuated Live Vaccine Sales Market Share by Type (2021-2033)

Figure 16：North America Varicella Attenuated Live Vaccine Revenue Market Share by Type (2021-2033)

Figure 17：North America Varicella Attenuated Live Vaccine Sales Market Share by Application (2021-2033)

Figure 18：North America Varicella Attenuated Live Vaccine Revenue Market Share by Application (2021-2033)

Figure 19：US Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 20：Canada Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 21：Europe Varicella Attenuated Live Vaccine Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 22：Europe Varicella Attenuated Live Vaccine Revenue Market Share by Players in 2025

Figure 23：Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2021-2033)

Figure 24：Europe Varicella Attenuated Live Vaccine Revenue Market Share by Type (2021-2033)

Figure 25：Europe Varicella Attenuated Live Vaccine Sales Market Share by Application (2021-2033)

Figure 26：Europe Varicella Attenuated Live Vaccine Revenue Market Share by Application (2021-2033)

Figure 27：Germany Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 28：France Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 29：United Kingdom Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 30：Italy Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 31：Spain Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 32：Benelux Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 33：China Varicella Attenuated Live Vaccine Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 34：China Varicella Attenuated Live Vaccine Revenue Market Share by Players in 2025

Figure 35：China Varicella Attenuated Live Vaccine Sales Market Share by Type (2021-2033)

Figure 36：China Varicella Attenuated Live Vaccine Revenue Market Share by Type (2021-2033)

Figure 37：China Varicella Attenuated Live Vaccine Sales Market Share by Application (2021-2033)

Figure 38：China Varicella Attenuated Live Vaccine Revenue Market Share by Application (2021-2033)

Figure 39：APAC (excl. China) Varicella Attenuated Live Vaccine Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 40：APAC (excl. China) Varicella Attenuated Live Vaccine Revenue Market Share by Players in 2025

Figure 41：APAC (excl. China) Varicella Attenuated Live Vaccine Sales Market Share by Type (2021-2033)

Figure 42：APAC (excl. China) Varicella Attenuated Live Vaccine Revenue Market Share by Type (2021-2033)

Figure 43：APAC (excl. China) Varicella Attenuated Live Vaccine Sales Market Share by Application (2021-2033)

Figure 44：APAC (excl. China) Varicella Attenuated Live Vaccine Revenue Market Share by Application (2021-2033)

Figure 45：Japan Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 46：South Korea Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 47：India Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 48：Australia Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 49：Southeast Asia Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 50：Latin America Varicella Attenuated Live Vaccine Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 51：Latin America Varicella Attenuated Live Vaccine Revenue Market Share by Players in 2025

Figure 52：Latin America Varicella Attenuated Live Vaccine Sales Market Share by Type (2021-2033)

Figure 53：Latin America Varicella Attenuated Live Vaccine Revenue Market Share by Type (2021-2033)

Figure 54：Latin America Varicella Attenuated Live Vaccine Sales Market Share by Application (2021-2033)

Figure 55：Latin America Varicella Attenuated Live Vaccine Revenue Market Share by Application (2021-2033)

Figure 56：Mexico Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 57：Brazil Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 58：Middle East & Africa Varicella Attenuated Live Vaccine Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 59：Middle East & Africa Varicella Attenuated Live Vaccine Revenue Market Share by Players in 2025

Figure 60：Middle East & Africa Varicella Attenuated Live Vaccine Sales Market Share by Type (2021-2033)

Figure 61：Middle East & Africa Varicella Attenuated Live Vaccine Revenue Market Share by Type (2021-2033)

Figure 62：Middle East & Africa Varicella Attenuated Live Vaccine Sales Market Share by Application (2021-2033)

Figure 63：Middle East & Africa Varicella Attenuated Live Vaccine Revenue Market Share by Application (2021-2033)

Figure 64：Saudi Arabia Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 65：South Africa Varicella Attenuated Live Vaccine Revenue (2021-2033) & (US$ Million)

Figure 66：Global Varicella Attenuated Live Vaccine Sales Market Share by Key Manufacturers in 2025

Figure 67：Global Varicella Attenuated Live Vaccine Revenue Market Share by Key Manufacturers in 2025

Figure 68：Global Varicella Attenuated Live Vaccine Industry Competition Landscape

Figure 69：Varicella Attenuated Live Vaccine Industry Chain Analysis

Figure 70：Bottom-Up and Top-Down Research Methods

Figure 71：Key Interview Objectives

Figure 72：Data Cross Validation

Competitor Data

Global Varicella Attenuated Live Vaccine Revenue, Sales and Market Share by Player

Revenue (US$ Million)	2020	2021	2022	2023	2024
Merck	XX	XX	XX	XX	XX
BCHT	XX	XX	XX	XX	XX
Shanghai Institute	XX	XX	XX	XX	XX
GSK	XX	XX	XX	XX	XX
Keygen	XX	XX	XX	XX	XX
Green Cross	XX	XX	XX	XX	XX
Biken	XX	XX	XX	XX	XX
Shanghai Rongsheng Biotech	XX	XX	XX	XX	XX
Sinovac Biotech	XX	XX	XX	XX	XX
Other Companies	XX	XX	XX	XX	XX
Total	XX	XX	XX	XX	XX

Sales (K Doses)	2020	2021	2022	2023	2024
Merck	XX	XX	XX	XX	XX
BCHT	XX	XX	XX	XX	XX
Shanghai Institute	XX	XX	XX	XX	XX
GSK	XX	XX	XX	XX	XX
Keygen	XX	XX	XX	XX	XX
Green Cross	XX	XX	XX	XX	XX
Biken	XX	XX	XX	XX	XX
Shanghai Rongsheng Biotech	XX	XX	XX	XX	XX
Sinovac Biotech	XX	XX	XX	XX	XX
Other Companies	XX	XX	XX	XX	XX
Total	XX	XX	XX	XX	XX

Please enter keywords

Related Report

Global Dydrogesterone Drug Competitive Landscape Professional Research Report 2026

Global Dydrogesterone Drug Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

Global Olanzapine Competitive Landscape Professional Research Report 2026

Global Olanzapine Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

Global Oligonucleotide Pool Library Competitive Landscape Professional Research Report 2026

Global Oligonucleotide Pool Library Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2026

Global Oligonucleotide Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

Order Process

Contact

1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you

2. You can also directly call our customer service hotline or add customer service WeChat

Samples

1. One on one business specialist will send the complete version of the sample

2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples

Payment

1. Both parties sign a report purchase contract

2. Support Paypal, Visa, UnionPay and MasterCard Payment

Delivery

1. PDF report (sent online 2-3 working days after payment)

2. WORD version report (sent online 2-3 working days after payment)

3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)

After-Sales

Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied

Didn't find the report you wanted? Please contact us!

DIResearch provides market research reports, focus on market segmentation research, industry research, market status and forecasts, players competition analysis, company positioning, downstream customer and product market analysis, etc. We effectively analyze complex data and information through professional methods, and finally present the research content of customer needs in the form of reports, helping companies make more valuable business decisions, helping companies improve operational efficiency and find new growth points.